Medicare Prescription Drug Coverage federal funding in FY2026

CFDA 93.770 overlapping FY2026

This page joins MEDICARE PRESCRIPTION DRUG COVERAGE to FY2026. $85,219,493,384.73 is the obligation sum on that pair. 901 FY-tagged awards underlie the cell. It is not every federal dollar in FY2026, not the program-wide $364,143,471,494.28 book, and not an outlay. CFDA 93.770 drops the year filter. FY2026 federal spending drops the listing filter.

Nine hundred one rows are not a plan census. Correlation with an unfinished year is not causation. Campaign-finance filings do not fund these USAspending obligations. Other Medicare CFDA keys on this slice keep their own FY2026 cells.

Medicare Prescription Drug Coverage as a catalog title in FY2026

The official title is MEDICARE PRESCRIPTION DRUG COVERAGE. SpendingVault does not grade eligibility rules or benefit formulas. $85,219,493,384.73 is an FY2026 obligation sum, not a policy verdict. Other Medicare CFDA keys on this slice keep their own FY2026 cells. Mixing those siblings into $85,219,493,384.73 would invent a combined total the packet never computed.

The program-wide book is $364,143,471,494.28 on 4625 extract-wide awards. This cell is FY2026 only. Other statistical series that share a popular name with Medicare Prescription Drug Coverage are not the 901 USAspending.gov awards.

FY2026 on the Medicare Prescription Drug Coverage yearlyTrend row

Fiscal year 2026 is the yearlyTrend year key. FY2026 figures can be incomplete for the current year. This page will not annualize $85,219,493,384.73. The FY cell is 23.4% of the program-wide $364,143,471,494.28 book in this extract. Do not treat 4625 extract-wide awards as a FY2026 instrument list. Do not divide $85,219,493,384.73 by 4625.

FY2026 federal spending is the government-wide year hub. All programs and All spending ties are parent indexes. None of those parents equals $85,219,493,384.73. Place-of-performance geography is unpublished here.

Nine hundred one FY2026 rows versus extract-wide 4625 awards

901 is the FY2026 award-record count. 4625 is the listing’s extract-wide count. 901 rows on an open year are a partial file. This page will not annualize the cell into a full-year drug budget. Unique recipients are unpublished. This page will not publish a typical invoice from mixing a one-year dollar field with a multi-year row field.

Keep Medicare Prescription Drug Coverage and FY2026 on the citation. Keep the obligation label. Correlation with an unfinished year is not causation.

Citing Medicare Prescription Drug Coverage in FY2026

Use CFDA 93.770 for CFDA 93.770, FY2026 federal spending for FY2026 federal spending, All programs for All programs, and All spending ties for All spending ties. Quote $85,219,493,384.73 as FY2026 obligations. USAspending.gov remains the source.

A ties page exists because two tables meet: CFDA 93.770 and FY2026. $85,219,493,384.73 is not a forecast. FEC donations do not fund this USAspending cell. If a later extract revises the rollup, this snapshot will be stale until rebuilt. FY2026 figures can be incomplete for the current year. This page will not annualize $85,219,493,384.73.

Original award filings remain on USAspending.gov. SpendingVault republishes the join as a catalog intersection. Keep both sides of the pair in any citation. Later bulk files can move the dollars and the award-record count. Treat this JSON as a packet snapshot rather than a permanent press total.

Do not invent contractors or award recipients. Do not convert obligations into outlays. Campaign-finance filings are a different public-record system and do not fund this USAspending cell. Use the internal links to step off this pair onto parent hubs.

The headline dollar figure is a commitment total on tagged awards, not a Treasury payment register. Award count is a row count and can include continuations and modifications. Unique recipients remain unpublished.

Cite the catalog listing and the second join key in the same sentence as the obligation sum. Parent hubs are larger than this cell and must not be added into the headline.

Questions

How much Medicare Prescription Drug Coverage funding was obligated in FY2026?

USAspending.gov records $85,219,493,384.73 in CFDA 93.770 obligations for FY2026 across 901 awards. That yearlyTrend amount is not an outlay and not the program-wide $364,143,471,494.28 book. Original filings remain on USAspending.gov.

Can I annualize the FY2026 prescription-drug cell?

No. FY2026 figures can be incomplete. 901 is a partial-year row count. This page does not forecast a full-year close. Original filings remain on USAspending.gov. The join is a catalog intersection, not a budget. Obligations remain commitments, not Treasury outlays.

Does this include supplementary medical insurance?

No. The cell is CFDA 93.770 only. Supplementary medical insurance is CFDA 93.774. Mixing them into $85,219,493,384.73 would invent a combined Medicare total. Original filings remain on USAspending.gov. The join is a catalog intersection, not a budget.

Does $85,219,493,384.73 equal Medicare Prescription Drug Coverage already paid in FY2026?

No. $85,219,493,384.73 is an obligation aggregate. Outlays and remaining balances are unpublished. FEC donations do not fund this USAspending cell. Original filings remain on USAspending.gov. The join is a catalog intersection, not a budget. Obligations remain commitments, not Treasury outlays.